Question
To ask the Secretary of State for Health and Social Care, what recent discussions her Department has had with pharmaceutical manufacturers on the availability of emergency hydrocortisone injection products.
Answer
In regards to the wider action being taken regarding the availability of emergency hydrocortisone injections, I refer the Hon. Member to the response given on 22 April to Question 126862 , and on 25 June to Question 9822 . Regarding the NHS Steroid Emergency Card, I refer the Hon. Member to the response given on 16 January 2025 to Question 23199 , referring to the following publication: https://www.england.nhs.uk/publication/national-patient-safety-alert-steroid-emergency-card-to-support-early-recognition-and-treatment-of-adrenal-crisis-in-adults/
Verdict: RED (20/100)
The question asked about the Department's engagement with pharmaceutical manufacturers. The reply does not describe that engagement itself. It refers the reader back to earlier answers on hydrocortisone injection availability and to the Steroid Emergency Card, so the subject is touched on but not substantively answered. The person who asked would likely need to ask again for specifics on what the Department has actually done with manufacturers.
How we got there
| Question item | Coverage | Specificity | Rationale |
|---|---|---|---|
| What is the nature of the Department's recent engagement with pharmaceutical manufacturers on the availability of emergency hydrocortisone injection products. | Partially Addressed | Hedged | The reply contains only referrals: it points to earlier answers on hydrocortisone injection availability (statement 1) and to the Steroid Emergency Card (statements 2 and 3), without itself describing the nature of the Department's engagement with pharmaceutical manufacturers. It touches the right subject but gives no concrete content about that engagement, so the item is only partly addressed. |